Correlation of serum inhibin concentrations with results in an ovarian hyperstimulation program. 1989

K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
Department of Gynecology and Obstetrics, Gunma University, Maebashi, Japan.

In order to appraise follicular development, human serum inhibin was measured daily by radioimmunoassay in 18 women undergoing ovarian hyperstimulation. Serum inhibin in the early follicular phase correlated with the number of follicles greater than or equal to 17 mm in diameter (r = 0.57, n = 18, P less than 0.05), follicles greater than or equal to 14 mm in diameter (r = 0.67, n = 18, P less than 0.01) on the day of human chorionic gonadotropin (hCG) administration and the number of oocytes retrieved (r = 0.67, n = 15, P less than 0.01). The number of oocytes retrieved showed a significant correlation with serum inhibin level on the day of hCG administration (r = 0.84, n = 15, P less than 0.001). These data suggest that: (1) In the early follicular phase, serum inhibin may be a valid index to predict ensuing follicular growth; (2) In the preovulatory phase, serum inhibin may be one of applicable indexes of follicular development during the hyperstimulation cycle.

UI MeSH Term Description Entries
D007265 Inhibins Glycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively Female Inhibin,Inhibin,Inhibin-F,Inhibins, Female,Inhibins, Testicular,Ovarian Inhibin,Testicular Inhibin,Female Inhibins,Inhibin F,Inhibin, Female,Inhibin, Ovarian,Inhibin, Testicular,Testicular Inhibins
D008297 Male Males
D008597 Menstrual Cycle The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase. Endometrial Cycle,Ovarian Cycle,Cycle, Endometrial,Cycle, Menstrual,Cycle, Ovarian,Cycles, Endometrial,Cycles, Menstrual,Cycles, Ovarian,Endometrial Cycles,Menstrual Cycles,Ovarian Cycles
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012099 Reproductive Techniques Methods pertaining to the generation of new individuals, including techniques used in selective BREEDING, cloning (CLONING, ORGANISM), and assisted reproduction (REPRODUCTIVE TECHNIQUES, ASSISTED). Reproductive Technology,Reproduction Technics,Reproduction Techniques,Reproductive Technologies,Technology, Reproductive,Reproduction Technic,Reproduction Technique,Reproductive Technique,Technic, Reproduction,Technics, Reproduction,Technique, Reproduction,Technique, Reproductive,Techniques, Reproduction,Techniques, Reproductive,Technologies, Reproductive
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females

Related Publications

K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
November 1993, The New England journal of medicine,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
October 2005, Zhonghua fu chan ke za zhi,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
September 2006, Journal de gynecologie, obstetrique et biologie de la reproduction,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
June 2017, Facts, views & vision in ObGyn,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
June 2009, Fertility and sterility,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
January 1991, Reproduction, fertility, and development,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
October 2000, Ginekologia polska,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
June 2006, Zhonghua fu chan ke za zhi,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
March 1994, British journal of haematology,
K Tsuchiya, and M Seki, and M Itoh, and Y Hasegawa, and K Miyamoto, and M Igarashi
January 2001, European journal of obstetrics, gynecology, and reproductive biology,
Copied contents to your clipboard!